newsfilter
← Latest News
Business Wire·

Intersect ENT Closes Acquisition of Fiagon AG Medical Technologies

MENLO PARK, Calif. & BERLIN--(BUSINESS WIRE)--Intersect ENT, Inc. (Nasdaq: XENT), a company transforming care for patients with ear, nose and throat (“ENT”) conditions, today announced it closed the previously announced transaction to acquire Fiagon AG Medical Technologies, a leader in electromagnetic surgical navigation solutions, for €60 million in cash.